Incidence of medulloblastoma in Canadian children
Donna L. Johnston(Children's Hospital of Eastern Ontario), Éric Bouffet(Hospital for Sick Children), Josée Brossard(Centre Hospitalier Universitaire de Sherbrooke), Maria Kostova(Children's Hospital of Eastern Ontario), Vanessa Percy(CancerCare Manitoba), Lucie Lafay‐Cousin(Women & Children's Hospital of Buffalo), Lynette Bowes(Janeway Children's Health and Rehabilitation Centre), Shayna Zelcer(London Health Sciences Centre), Adam Fleming(Montreal Children's Hospital), Anne‐Sophie Carret(Montreal Neurological Institute and Hospital), Chris Mpofu(Saskatchewan Cancer Agency), Daniel Keene, Valérie Larouche, Mariana Silva(Kingston General Hospital), Samina Afzal, Douglas Strother(Women & Children's Hospital of Buffalo), Chris Fryer(BC Children's Hospital), Beverly Wilson(University of Alberta), Katrin Scheinemann(University of Lucerne)
Cited by 21
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
|Acta Neuropathologica|2012|1k
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853
Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795